Tanya Das

Kolkata, WB 700091, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy.

Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy.

Journal: Apoptosis : an international journal on programmed cell death

Published: April 06, 2026

Author Correction: Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts.

Author Correction: Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts.

Journal: Cellular & molecular immunology

Published: October 14, 2025

Cancer Stem Cells Decide the Fate of Cancer Immunotherapy by Remodeling Tumor Microenvironment.

Cancer Stem Cells Decide the Fate of Cancer Immunotherapy by Remodeling Tumor Microenvironment.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: September 24, 2025

Corrigendum to "Tumor-induced thymic involution via inhibition of IL-7Rα and its JAK-STAT signaling pathway: Protection by black tea" [Int. Immunopharmacol. 6(3) (2006) 433-444].

Corrigendum to "Tumor-induced thymic involution via inhibition of IL-7Rα and its JAK-STAT signaling pathway: Protection by black tea" [Int. Immunopharmacol. 6(3) (2006) 433-444].

Journal: International immunopharmacology

Published: August 27, 2025

Tumor-infiltrating lymphocytes and tumor-associated macrophages in cancer immunoediting: a targetable therapeutic axis.

Tumor-infiltrating lymphocytes and tumor-associated macrophages in cancer immunoediting: a targetable therapeutic axis.

Journal: Frontiers in immunology

Published: June 27, 2025

In-silico analysis unveiling the role of cancer stem cells in immunotherapy resistance of immune checkpoint-high pancreatic adenocarcinoma.

In-silico analysis unveiling the role of cancer stem cells in immunotherapy resistance of immune checkpoint-high pancreatic adenocarcinoma.

Journal: Scientific reports

Published: November 06, 2024

hsa-miR-5688 inhibits FOXC1-OCT4/SOX2 feedforward loop that drives chemoresistance in breast cancer stem cells.

hsa-miR-5688 inhibits FOXC1-OCT4/SOX2 feedforward loop that drives chemoresistance in breast cancer stem cells.

Journal: Molecular therapy. Oncology

Published: September 28, 2024

Bryophyllum pinnatum Induces p53-Dependent Apoptosis of Colorectal Cancer Cells via Increased Intracellular ROS and G2/M Cell-Cycle Arrest In Vitro and Validated in Silico by Molecular Docking.

Bryophyllum pinnatum Induces p53-Dependent Apoptosis of Colorectal Cancer Cells via Increased Intracellular ROS and G2/M Cell-Cycle Arrest In Vitro and Validated in Silico by Molecular Docking.

Journal: Cell biology international

Published: September 27, 2024

Breast cancer stem cells convert anti-tumor CD4+ T cells to pro-tumor T regulatory cells: Potential role of exosomal FOXP3.

Breast cancer stem cells convert anti-tumor CD4+ T cells to pro-tumor T regulatory cells: Potential role of exosomal FOXP3.

Journal: Cellular immunology

Published: July 24, 2024

ALTering Cancer by Triggering Telomere Replication Stress through the Stabilization of Promoter G-Quadruplex in SMARCAL1.

ALTering Cancer by Triggering Telomere Replication Stress through the Stabilization of Promoter G-Quadruplex in SMARCAL1.

Journal: ACS chemical biology

Published: July 03, 2024

Tumor-associated macrophages: an effective player of the tumor microenvironment.

Tumor-associated macrophages: an effective player of the tumor microenvironment.

Journal: Frontiers in immunology

Published: September 15, 2023

Breast cancer stem cells generate immune-suppressive T regulatory cells by secreting TGFβ to evade immune-elimination.

Breast cancer stem cells generate immune-suppressive T regulatory cells by secreting TGFβ to evade immune-elimination.

Journal: Discover oncology

Published: May 28, 2023

Showing 1-12 of 51

Last Updated: 09/26/2026